Find News

Filter articles

Applied Filters

Showing 81 to 90 of 1072 results

Apotex asks Supreme Court to overturn Teva ‘Bendeka’ ruling

US21-12-2021Alex Baldwin

Apotex has asked the US Supreme Court to reconsider a US Court of Appeals for the Federal Circuit ruling upholding four of Teva Pharmaceutical’s cancer drug patents.

BioDelivery Sciences ‘pleased’ with mixed ruling over Opioid drug claims

US21-12-2021Alex Baldwin

A Delaware Federal Court has upheld some of the validity of challenged claims in two patents related to BioDelivery Sciences’ opioid medication Belbuca, but invalidated others.

Gilead, BMS, Janssen facing HIV generic antitrust suit

US16-12-2021Muireann Bolger

Gilead, Bristol-Myers Squibb and Janssen are facing accusations that they suppressed competition in the market for drugs used to treat the human immunodeficiency virus.

Intubated patients sedative patent the focus of ACS Dobfar suit

US16-12-2021Alex Baldwin

Sun Pharmaceutical has been sued by ACS Dobfar subsidiary InfoRLife and WG Critical Care for allegedly infringing on a patent with its proposed midazolam-an anaesthesia medication.

Generics win anti-pay-for-delay bill challenge

US14-12-2021Alex Baldwin

The Association for Accessible Medicines, which represents manufacturers of generics and biosimilars, has succeeded in challenging a California bill that characterises “reverse payment” or “pay-for-delay” patent settlements as anticompetitive and unlawful.

Pharmavite accuses Bausch, GSK of ‘sham’ patent litigation

US13-12-2021Alex Baldwin

Nutritional supplements manufacturer Pharmavite has filed an antitrust suit against Bausch & Lomb and GlaxoSmithKline, claiming that they are filing sham patent litigation related to its “PreserVision” products.

GSK responds to Teva’s ‘skinny’ label rehearing petition

US09-12-2021Alex Baldwin

Following a substantial push from generics companies to reverse the GSK v Teva “skinny” label ruling, GlaxoSmithKilne has added its response to the petition to rehear the case yet again.

Teva loses appeal to invalidate Korlym patent

US09-12-2021Alex Baldwin

Teva Pharmaceuticals has failed to convince the US Court of Appeal for the Federal Circuit that a Corcept Therapeutics method patent for Korlym was invalid.

Mylan gets Fed Circ reprieve in inhaler dispute

US09-12-2021Muireann Bolger

Mylan has been allowed to revisit a decision holding that it infringed patents covering AstraZeneca's inhaler asthma treatment, Symbicort.

Galderma sues Lupin over Oracea generic

US07-12-2021Alex Baldwin

Galderma Laboratories has sued Lupin Pharmaceuticals alleging that it plans to manufacture and sell a generic version of Oracea prior to the expiration of key patents.

Showing 81 to 90 of 1072 results